[1]CurrentPatentAssignee:THERAVANCEBIOPHARMA,INC.-US2015/210690,2015,A1Locationinpatent:Paragraph0231;0863
[2]CurrentPatentAssignee:THERAVANCEBIOPHARMA,INC.-WO2015/116786,2015,A1Locationinpatent:Page/Pagecolumn230
1380571-72-1
1359655-43-8
1523530-72-4
1803592-63-3
1864072-41-2
937647-22-8 | 5-Bromo-2-(methylamino)pyrimidine-4-carboxylic acid | AA00IHR2 | MFCD09837146
943320-50-1 | 3-Iodo-4-methyl-n-(4-((4-methylpiperazin-1-yl)methyl)-3-(trifluoromethyl)phenyl)benzamide | AA00IHZI | MFCD22572796
944896-82-6 | 5-Chloroimidazol[1,2-a]pyrimidine | AA00II54 | MFCD10698094
946682-32-2 | (R,S)-Fmoc-3-(t-butyl)-beta-ala-oh | AA00IICU | MFCD09264210
94832-39-0 | 8-Fluoro-5-nitroquinoline | AA00III9 | MFCD09048716
951624-24-1 | 6-(Methoxymethoxy)-1h-indazol-3-amine | AA00IIPC | MFCD09788619
952514-79-3 | Boronic acid, b-[4-(1-phenyl-1h-benzimidazol-2-yl)phenyl]- | AA00IITD | MFCD11045057
955315-33-0 | 6-(2,8-Bis-trifluoromethyl-quinolin-4-ylmethyl)-pyridin-3-ol | AA00IJ3V | MFCD05863553
956571-07-6 | 5-Chloro-4-(chloromethyl)-1,3-dimethyl-1H-pyrazole | AA00IJ8L | MFCD08729251
957793-35-0 | Cis-3-aminocyclobutanecarboxylic acid ethyl ester hydrochloride | AA00IJDG | MFCD12925784
